Login to Your Account

Top 5 Firms Control 70%

Biologics Manufacturing Grows, But Small Firms Won't Benefit

By Nuala Moran
BioWorld International Correspondent

Wednesday, December 7, 2011
GLASGOW, SCOTLAND – The global capacity for manufacturing biologics is growing, but most facilities are controlled by a few major companies and used for their own products, creating difficulties for smaller biotechs with products that are approaching commercialization.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription